Trial Profile
Activity and Safety of Eribulin in a Real-World Population of Metastatic Breast Cancer (MBC) Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Aug 2018
Price :
$35
*
At a glance
- Drugs Eribulin (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 14 Aug 2018 New trial record